Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8507644rdf:typepubmed:Citationlld:pubmed
pubmed-article:8507644lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C0162807lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C0205666lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C0439810lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C0260249lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C0597177lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:8507644lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:8507644pubmed:issue23lld:pubmed
pubmed-article:8507644pubmed:dateCreated1993-7-9lld:pubmed
pubmed-article:8507644pubmed:abstractTextThe secondary structure of the human low-density lipoprotein (LDL) apo B-100 fragment embedded in the lipid domain of the particle has been investigated by Fourier transform attenuated total reflection infrared spectroscopy (FTIR-ATR). The solvent-exposed region of the protein was hydrolyzed by using different proteases (alpha-chymotrypsin, trypsin, proteinase K) for incubation times varying between 24 min and 48 h. Analysis of the FTIR-ATR spectra after repurification of the digested LDL particle indicates the same trend for all the hydrolysis conditions tested: the peptides remaining associated with the particle are rich in beta-sheet structure. Dichroism spectra reveal that at least part of the beta-sheets is associated with the phospholipid component of the particle.lld:pubmed
pubmed-article:8507644pubmed:languageenglld:pubmed
pubmed-article:8507644pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:citationSubsetIMlld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8507644pubmed:statusMEDLINElld:pubmed
pubmed-article:8507644pubmed:monthJunlld:pubmed
pubmed-article:8507644pubmed:issn0006-2960lld:pubmed
pubmed-article:8507644pubmed:authorpubmed-author:RuysschaertJ...lld:pubmed
pubmed-article:8507644pubmed:authorpubmed-author:RosseneuMMlld:pubmed
pubmed-article:8507644pubmed:authorpubmed-author:GoormaghtighE...lld:pubmed
pubmed-article:8507644pubmed:authorpubmed-author:CabiauxVVlld:pubmed
pubmed-article:8507644pubmed:authorpubmed-author:De MeutterJJlld:pubmed
pubmed-article:8507644pubmed:issnTypePrintlld:pubmed
pubmed-article:8507644pubmed:day15lld:pubmed
pubmed-article:8507644pubmed:volume32lld:pubmed
pubmed-article:8507644pubmed:ownerNLMlld:pubmed
pubmed-article:8507644pubmed:authorsCompleteYlld:pubmed
pubmed-article:8507644pubmed:pagination6104-10lld:pubmed
pubmed-article:8507644pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:meshHeadingpubmed-meshheading:8507644-...lld:pubmed
pubmed-article:8507644pubmed:year1993lld:pubmed
pubmed-article:8507644pubmed:articleTitleSecondary structure of the particle associating domain of apolipoprotein B-100 in low-density lipoprotein by attenuated total reflection infrared spectroscopy.lld:pubmed
pubmed-article:8507644pubmed:affiliationLaboratoire de Chimie Physique des Macromolécules aux Interfaces, Université Libre de Bruxelles, Belgium.lld:pubmed
pubmed-article:8507644pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8507644pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8507644lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8507644lld:pubmed